191 related articles for article (PubMed ID: 21739429)
1. The central role of CD30L/CD30 interactions in allergic rhinitis pathogenesis in mice.
Fuchiwaki T; Sun X; Fujimura K; Yamada H; Shibata K; Muta H; Podack ER; Kawauchi H; Yoshikai Y
Eur J Immunol; 2011 Oct; 41(10):2947-54. PubMed ID: 21739429
[TBL] [Abstract][Full Text] [Related]
2. IL-15 prevents allergic rhinitis through reactivation of antigen-specific CD8+ cells.
Aoi N; Masuda T; Murakami D; Yajima T; Mizubuchi H; Yamada H; Kawauchi H; Yoshikai Y
J Allergy Clin Immunol; 2006 Jun; 117(6):1359-66. PubMed ID: 16750998
[TBL] [Abstract][Full Text] [Related]
3. CD30 ligand/CD30 plays a critical role in Th17 differentiation in mice.
Sun X; Yamada H; Shibata K; Muta H; Tani K; Podack ER; Yoshikai Y
J Immunol; 2010 Aug; 185(4):2222-30. PubMed ID: 20639486
[TBL] [Abstract][Full Text] [Related]
4. IL-16 variability and modulation by antiallergic drugs in a murine experimental allergic rhinitis model.
Akiyama K; Karaki M; Kobayshi R; Dobashi H; Ishida T; Mori N
Int Arch Allergy Immunol; 2009; 149(4):315-22. PubMed ID: 19295235
[TBL] [Abstract][Full Text] [Related]
5. An essential role for dendritic cells in human and experimental allergic rhinitis.
KleinJan A; Willart M; van Rijt LS; Braunstahl GJ; Leman K; Jung S; Hoogsteden HC; Lambrecht BN
J Allergy Clin Immunol; 2006 Nov; 118(5):1117-25. PubMed ID: 17088138
[TBL] [Abstract][Full Text] [Related]
6. Amelioration of experimental allergic rhinitis with suppression of topical immune responses by lack of IL-27/WSX-1 signaling.
Shimanoe Y; Miyazaki Y; Hara H; Inokuchi A; Yoshida H
Ann Allergy Asthma Immunol; 2009 Mar; 102(3):223-32. PubMed ID: 19354069
[TBL] [Abstract][Full Text] [Related]
7. Direct evidence for a critical role of CD30 in the development of allergic asthma.
Polte T; Behrendt AK; Hansen G
J Allergy Clin Immunol; 2006 Oct; 118(4):942-8. PubMed ID: 17030250
[TBL] [Abstract][Full Text] [Related]
8. United airways: circulating Th2 effector cells in an allergic rhinitis model are responsible for promoting lower airways inflammation.
KleinJan A; Willart M; van Nimwegen M; Leman K; Hoogsteden HC; Hendriks RW; Lambrecht BN
Clin Exp Allergy; 2010 Mar; 40(3):494-504. PubMed ID: 19968652
[TBL] [Abstract][Full Text] [Related]
9. Immunostimulatory sequence oligdeoxynucleotide/cholera toxin B conjugate: a novel allergen-independent intranasal vaccine for allergic rhinitis.
Won TB; Quan SH; Kim DY; Rhee CS; Lee CH
Ann Allergy Asthma Immunol; 2009 Apr; 102(4):314-22. PubMed ID: 19441603
[TBL] [Abstract][Full Text] [Related]
10. Existence of antigen-specific immunoglobulin E is not sufficient for allergic nasal eosinophil infiltration in mice.
Nishimura T; Saeki M; Kaminuma O; Matsuoka K; Yonekawa H; Mori A; Hiroi T
Int Arch Allergy Immunol; 2013; 161 Suppl 2():125-8. PubMed ID: 23711863
[TBL] [Abstract][Full Text] [Related]
11. Listeriolysin O derived from Listeria monocytogenes inhibits the effector phase of an experimental allergic rhinitis induced by ovalbumin in mice.
Yamamoto K; Kawamura I; Tominaga T; Nomura T; Ito J; Mitsuyama M
Clin Exp Immunol; 2006 Jun; 144(3):475-84. PubMed ID: 16734617
[TBL] [Abstract][Full Text] [Related]
12. Intranasal application of Epstein-Barr virus/lipoplex to abrogate eosinophillia in murine model of allergic rhinitis.
Han DM; Zhou B; Wang T; Wang XD; Fan EZ
Chin Med J (Engl); 2006 Jun; 119(12):991-7. PubMed ID: 16805982
[TBL] [Abstract][Full Text] [Related]
13. CD30 ligand is a target for a novel biological therapy against colitis associated with Th17 responses.
Sun X; Yamada H; Shibata K; Muta H; Tani K; Podack ER; Iwakura Y; Yoshikai Y
J Immunol; 2010 Dec; 185(12):7671-80. PubMed ID: 21068411
[TBL] [Abstract][Full Text] [Related]
14. CD30 ligand is a new therapeutic target for central nervous system autoimmunity.
Shinoda K; Sun X; Oyamada A; Yamada H; Muta H; Podack ER; Kira J; Yoshikai Y
J Autoimmun; 2015 Feb; 57():14-23. PubMed ID: 25533628
[TBL] [Abstract][Full Text] [Related]
15. A critical role of CD30 ligand/CD30 in controlling inflammatory bowel diseases in mice.
Sun X; Somada S; Shibata K; Muta H; Yamada H; Yoshihara H; Honda K; Nakamura K; Takayanagi R; Tani K; Podack ER; Yoshikai Y
Gastroenterology; 2008 Feb; 134(2):447-58. PubMed ID: 18242212
[TBL] [Abstract][Full Text] [Related]
16. Role of NOD1-mediated signals in a mouse model of allergic rhinitis.
Shin JH; Kim SW; Park YS
Otolaryngol Head Neck Surg; 2012 Dec; 147(6):1020-6. PubMed ID: 23032918
[TBL] [Abstract][Full Text] [Related]
17. Allergic rhinitis induced by intranasal sensitization and challenge with trimellitic anhydride but not with dinitrochlorobenzene or oxazolone in A/J mice.
Farraj AK; Harkema JR; Kaminski NE
Toxicol Sci; 2004 Jun; 79(2):315-25. PubMed ID: 15056815
[TBL] [Abstract][Full Text] [Related]
18. Lactate dehydrogenase-elevating virus infection at the sensitization and challenge phases reduces the development of delayed eosinophilic allergic rhinitis in BALB/c mice.
Sasaki Y; Hayashi T; Hasegawa K
Scand J Immunol; 2007 Dec; 66(6):628-35. PubMed ID: 17949409
[TBL] [Abstract][Full Text] [Related]
19. Implications of nasopharynx-associated lymphoid tissue (NALT) in the development of allergic responses in an allergic rhinitis mouse model.
Kim DY; Fukuyama S; Nagatake T; Takamura K; Kong IG; Yokota Y; Lee CH; Kiyono H
Allergy; 2012 Apr; 67(4):502-9. PubMed ID: 22257110
[TBL] [Abstract][Full Text] [Related]
20. Immunomodulatory effects of IL-23 and IL-17 in a mouse model of allergic rhinitis.
Wang M; Zhang W; Shang J; Yang J; Zhang L; Bachert C
Clin Exp Allergy; 2013 Aug; 43(8):956-66. PubMed ID: 23889249
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
